Table 1 Projected outcomes of health from 2023 to 2050
From: The macroeconomic burden of hepatitis C and the economic benefit of accelerated investments in China
Scenario 1: Status quo | Scenario 2: WHO coverage target achieved in 2030 | Scenario 3: WHO coverage target achieved in 2040 | Scenario 4: WHO coverage target achieved in 2050 | |
|---|---|---|---|---|
Cumulative incident CHC(million) | 7.09(6.76, 7.46) | 3.10(2.96, 3.26) | 4.11(3.92, 4.32) | 5.00(4.77, 5.26) |
Cumulative incident HCC(million) | 1.19(1.05, 1.31) | 0.52(0.47,0.57) | 0.66(0.60, 0.73) | 0.82(0.73, 0.90) |
Cumulative HCV attributable deaths(million) | 1.88(1.75, 2.01) | 0.77(0.73, 0.83) | 1.00(0.94, 1.07) | 1.24(1.16, 1.32) |
Cumulative HCV attributable DALYs(million) | 13.21(12.40, 14.12) | 6.90(6.51, 7.34) | 8.88(8.36, 9.47) | 10.29(9.67, 10.98) |